Public Summary Document – March 2014 PBAC Meeting 5.8 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, fluticasone furoate 100 microgram actuation vilanterol - Fluticasone propionate - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-03-23 21:11:42 GlaxoSmithKline Glucocorticoids Asthma Organofluorides Fluticasone/salmeterol Salmeterol Formoterol Fluticasone propionate Fluticasone furoate Pulmonology Medicine Respiratory therapy		Public Summary Document – March 2014 PBAC Meeting 5.8 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, fluticasone furoate 100 microgram/actuation + vilanterol Add to Reading List Source URL: www.pbs.gov.au Download Document from Source Website File Size: 290,01 KB Share Document on Facebook

	7.10 FLUTICASONE+VILANTEROL, dry powder inhaler, fluticasone furoate 100 microgram/actuation + vilanterol (as trifenatate) 25 microgram/actuation, Breo® Ellipta®, GlaxoSmithKline Australia Pty Ltd. DocID: 18obH - View Document
	Public Summary Document – March 2014 PBAC Meeting 5.8 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, fluticasone furoate 100 microgram/actuation + vilanterol DocID: 12AGF - View Document
	Intranasal Corticosteroid Safety REVIEW Local and Systemic Safety of Intranasal Corticosteroids DocID: NtqQ - View Document
	Relief for sufferers of seasonal allergic rhinitis: Avamys now available in Canada DocID: Jzvs - View Document
	Microsoft PowerPoint - Q-Top 10 Questions_April 8.pptx DocID: GAh1 - View Document